Slivnick J, Lampert BC. Hypertension and heart failure. Heart Fail Clin. 2019;15(4):531–41.

Article  PubMed  Google Scholar 

Sinnenberg L, Givertz MM. Acute heart failure. Trends Cardiovasc Med. 2020;30(2):104–12.

Article  PubMed  Google Scholar 

Galiè N, McLaughlin VV, Rubin LJ, Simonneau G. An overview of the 6th World Symposium on Pulmonary Hypertension. Eur Respir J. 2019, 53(1).

Condon DF, Nickel NP, Anderson R, Mirza S, de Jesus Perez VA. The world symposium on pulmonary hypertension: what’s old is new. F1000Research. 2019. https://doi.org/10.12688/f1000research.18811.1.

Article  PubMed  PubMed Central  Google Scholar 

Xu W, Janocha AJ, Erzurum SC. Metabolism in pulmonary hypertension. Annu Rev Physiol. 2021;83:551–76.

Article  CAS  PubMed Central  Google Scholar 

Murphy C, Zafar H, Sharif F. An updated review of cardiac devices in heart failure. Ir J Med Sci. 2017;186(4):909–19.

Article  CAS  PubMed  Google Scholar 

Schleifer JW, Mookadam F, Kransdorf EP, Nanda U, Adams JC, Cha S, Pajaro OE, Steidley DE, Scott RL, Carvajal T. Effect of continued cardiac resynchronization therapy on ventricular arrhythmias after left ventricular assist device implantation. Am J Cardiol. 2016;118(4):556–9.

Article  PubMed  Google Scholar 

Lin A, Ho G. Cardiac resynchronization therapy in patients with left ventricular assist devices. In: Case-based device therapy for heart failure. Springer; 2021. p. 337–41.

Zeitler EP, Abraham WT. Novel devices in heart failure: BAT, atrial shunts, and phrenic nerve stimulation. JACC Heart Fail. 2020;8(4):251–64.

Article  PubMed  Google Scholar 

Paitazoglou C, Bergmann MW, Özdemir R, Pfister R, Bartunek J, Kilic T, Lauten A, Schmeisser A, Zoghi M, Anker SD. One-year results of the first-in-man study investigating the atrial flow regulator for left atrial shunting in symptomatic heart failure patients: the PRELIEVE study. Eur J Heart Fail. 2021;23(5):800–10.

Article  PubMed  Google Scholar 

Kaley V, Dahdah N, El-Sisi A, Grohmann J, Rosenthal E, Jones M, Morgan G, Hayes N, Shah A, Karakurt C. Atrial septal defect–associated pulmonary hypertension: outcomes of closure with a fenestrated device. Adv Pulm Hypertens. 2019;18(1):4–9.

Article  Google Scholar 

Akseer S, Horlick E, Vishwanath V, Hobbes B, Huszti E, Mak S, Lee DS, Abrahamyan L. Prevalence and outcomes of pulmonary hypertension after percutaneous closure of atrial septal defect: a systematic review and meta-analysis. Eur Respir Rev. 2020;29:158.

Article  Google Scholar 

Trevor S, Marino L, Firas Z, Babak N, William G, James H, Sunit-Preet C, Leonardo G, Franois P, Peter E. Percutaneous atriotomy for levoatrial-to-coronary sinus shunting insymptomatic heartfailure: first-in-human experience. JACC Cardiovasc Interv. 2020;13(10):1236–47.

Article  Google Scholar 

Shang X, Liu M, Zhong Y, Wang X, Chen S, Fu X, Sun M, Xie M, Ke Y, Guan Y. Clinical study on the treatment of chronic heart failure with a novel D‐shant atrium shunt device. ESC Heart Fail. 2022.

Griffin JM, Borlaug BA, Komtebedde J, Litwin SE, Shah SJ, Kaye DM, Hoendermis E, Hasenfuß G, Gustafsson F, Wolsk E. Impact of interatrial shunts on invasive hemodynamics and exercise tolerance in patients with heart failure. J Am Heart Assoc. 2020;9(17):e016760.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nanayakkara S, Kaye DM. Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction. Heart Fail Rev. 2023;28(2):281–6.

PubMed  Google Scholar 

Galiè N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67–119.

Article  PubMed  Google Scholar 

Vanhie E, VandeKerckhove K, Haas NA, De Wolf D. Atrial flow regulator for drug-resistant pulmonary hypertension in a young child. Catheter Cardiovasc Interv. 2021;97(6):E830–4.

Article  PubMed  Google Scholar 

Huang D, Hua W, Fang Q, Yan J, Su Y, Liu B, Xu Y, Peng Y, Investigators PC. Biventricular pacemaker and defibrillator implantation in patients with chronic heart failure in China. ESC Heart Fail. 2021;8(1):546–54.

Article  PubMed  Google Scholar 

Meng F, Zhang Z, Hou X, Qian Z, Wang Y, Chen Y, Wang Y, Zhou Y, Chen Z, Zhang X. Machine learning for prediction of sudden cardiac death in heart failure patients with low left ventricular ejection fraction: study protocol for a retroprospective multicentre registry in China. BMJ Open. 2019;9(5):e023724.

Article  PubMed  PubMed Central  Google Scholar 

Kaye DM, Hasenfuss G, Neuzil P, Post MC, Doughty R, Trochu J-N, Kolodziej A, Westenfeld R, Penicka M, Rosenberg M. One-year outcomes after transcatheter insertion of an interatrial shunt device for the management of heart failure with preserved ejection fraction. Circul Heart Fail. 2016;9(12):e003662.

Article  Google Scholar 

Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J, Lam CS, Ponikowski P, Voors AA, Jia G. Vericiguat in patients with heart failure and reduced ejection fraction. N Engl J Med. 2020;382(20):1883–93.

Article  CAS  PubMed  Google Scholar 

Upadhya B, Kitzman DW. Heart failure with preserved ejection fraction: new approaches to diagnosis and management. Clin Cardiol. 2020;43(2):145–55.

Article  PubMed  Google Scholar 

Giannitsi S, Bougiakli M, Bechlioulis A, Kotsia A, Michalis LK, Naka KK. 6-minute walking test: a useful tool in the management of heart failure patients. Therap Adv Cardiovasc Dis. 2019;13:1753944719870084.

Google Scholar 

Capota R, Militaru S, Ionescu AA, Rosca M, Jurcut R. Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire. Health Qual Life Outcomes. 2020;18(1):351.

Article  PubMed  PubMed Central  Google Scholar 

Zoghbi WA, Levine RA, Flachskampf F, Grayburn P, Gillam L, Leipsic J, Thomas JD, Kwong RY, Vandervoort P, Chandrashekhar Y. Atrial functional mitral regurgitation: a JACC: cardiovascular imaging expert panel viewpoint. JACC Cardiovasc Imaging. 2022;15(11):1870–82.

Article  PubMed  Google Scholar 

Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000;35(5):1245–55.

Article  CAS  PubMed  Google Scholar 

Creber RM, Polomano R, Farrar J, Riegel B. Psychometric properties of the Kansas City cardiomyopathy questionnaire (KCCQ). Eur J Cardiovasc Nurs. 2012;11(2):197–206.

Article  PubMed Central  Google Scholar 

Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364(15):1395–406.

Article  CAS  PubMed  Google Scholar 

Nakwan N, Jain S, Kumar K, Hosono S, Hammoud M, Elsayed YY, Ariff S, Hasan B, Khowaja W, Poon WB. An Asian multicenter retrospective study on persistent pulmonary hypertension of the newborn: incidence, etiology, diagnosis, treatment and outcome. J Matern Fetal Neonatal Med. 2020;33(12):2032–7.

Article  PubMed  Google Scholar 

Ranchoux B, Nadeau V, Bourgeois A, Provencher S, Tremblay É, Omura J, Coté N, et al. Metabolic syndrome exacerbates pulmonary hypertension due to left heart disease. Circ Res. 2019;125(4):449–66.

Article  CAS  PubMed  Google Scholar 

Kaemmerer H, Apitz C, Brockmeier K, Eicken A, Gorenflo M, Hager A, de Haan F, Huntgeburth M, Kozlik-Feldmann RG, Miera O. Pulmonary hypertension in adults with congenital heart disease: updated recommendations from the Cologne Consensus Conference 2018. Int J Cardiol. 2018;272:79–88.

Article  Google Scholar 

Rich S, Lam W. Atrial septostomy as palliative therapy for refractory primary pulmonary hypertension. Am J Cardiol. 1983;51(9):1560–1.

Article  CAS  PubMed  Google Scholar 

Rich S, Dodin E, McLaughlin VV. Usefulness of atrial septostomy as a treatment for primary pulmonary hypertension and guidelines for its application. Am J Cardiol. 1997;80(3):369–71.

Article  CAS  PubMed  Google Scholar 

Lammers AE, Derrick G, Haworth SG, Bonhoeffer P, Yates R. Efficacy and long-term patency of fenestrated amplatzer devices in children. Catheter Cardiovasc Interv. 2007;70(4):578–84.

Article  PubMed  Google Scholar 

Kerstein D, Levy PS, Hsu DT, Hordof AJ, Gersony WM, Barst RJ. Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension. Circulation. 1995;91(7):2028–35.

Article  CAS  PubMed  Google Scholar 

Baglini R. Atrial septostomy in patients with end-stage pulmonary hypertension. No more needles but wires, energy and close anatomical definition. J Interv Cardiol. 2013;26(1):62–8.

Article  PubMed  Google Scholar 

Obokata M, Reddy YN, Shah SJ, Kaye DM, Gustafsson F, Hasenfuβ G, Hoendermis E, Litwin SE, Komtebedde J, Lam C. Effects of interatrial shunt on pulmonary vascular function in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2019;74(21):2539–50.

Article  PubMed  Google Scholar 

Amat-Santos IJ, Bergeron S, Bernier M, Allende R, Ribeiro HB, Urena M, Pibarot P, Verheye S, Keren G, Yaacoby M. Left atrial decompression through unidirectional left-to-right interatrial shunt for the treatment of left heart failure: first-in-man experience with the V-Wave device. EuroInterv J EuroPCR Collab Work Group Interv Cardiol Eur Soc Cardiol. 2015;10(9):11278.

Google Scholar 

Patel MB, Samuel BP, Girgis RE, Parlmer MA, Vettukattil JJ. 13. Implantable atrial flow regulator for severe irreversible pulmonary arterial hypertension. In: Pediatric and adult interventional cardiac symposium: 2015; 2015.

Zheng W, Wang Z, Jiang X, Zhao Q, Shen J. Targeted drugs for treatment of pulmonary arterial hypertension: past, present, and future perspectives. J Med Chem. 2020;63(24):15153–86.

Article  CAS  Google Scholar